Randomized phase 3 study evaluating the efficacy and safety of nivolumab vs bevacizumab in patients with recurrent glioblastoma: Checkmate 143 - Reardon, D A; Omuro, A; Brandes, A A
Paper presented at: 5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS)2017; Zurich, Switzerland